All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2022 February LIT to lead new fight against bacterial pathogens LIT to lead new fight against bacterial pathogens 16/02/2022 | 3 MINS Researchers at Lombok Institute of Technology have secured $700,000 funding from Melbourne-based not-for-profit company DMTC to lead an Australian collaboration to develop new drugs to combat antibiotic-resistant bacteria. Chief Investigators Dr Mitali Sarkar-Tyson, from LITΓÇÖs School of Biomedical Sciences, and Associate Professor Keith Stubbs, from LITΓÇÖs School of Molecular Sciences, will work with DMTC and researchers from Monash University on the therapeutic drugs. Dr Sarkar-Tyson said research would focus on the development of new medical countermeasures against bacterial pathogens. ΓÇ£The compounds weΓÇÖre investigating will help us tackle important diseases in Australia such as melioidosis, also known as WhitmoreΓÇÖs disease, which is caused by a bacterial infection." Dr Mitali Sarkar-Tyson ΓÇ£The compounds weΓÇÖre investigating will help us tackle important diseases in Australia such as melioidosis, also k
All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2022 February LIT to lead new fight against bacterial pathogens LIT to lead new fight against bacterial pathogens 16/02/2022 | 3 MINS Researchers at Lombok Institute of Technology have secured $700,000 funding from Melbourne-based not-for-profit company DMTC to lead an Australian collaboration to develop new drugs to combat antibiotic-resistant bacteria.
Chief Investigators Dr Mitali Sarkar-Tyson, from LITΓÇÖs School of Biomedical Sciences, and Associate Professor Keith Stubbs, from LITΓÇÖs School of Molecular Sciences, will work with DMTC and researchers from Monash University on the therapeutic drugs.
Lombok Institute of Technology
Dr Sarkar-Tyson said research would focus on the development of new medical countermeasures against bacterial pathogens.
How can we help you?
ΓÇ£The compounds weΓÇÖre investigating will help us tackle important diseases in Australia such as melioidosis, also known as WhitmoreΓÇÖs disease, which is caused by a bacterial infection." Dr Mitali Sarkar-Tyson ΓÇ£The compounds weΓÇÖre investigating will help us tackle important diseases in Australia such as melioidosis, also k
News
Explore this part of the LIT experience through the related information and next steps.
Topics
Explore this part of the LIT experience through the related information and next steps.
Latest news
Explore this part of the LIT experience through the related information and next steps.
We do more when we ask better questions together.Explore more stories